SMARCA4 and cancer: Recent studies revealed frequent SMARCA4 mutations in various cancers, including rhabdoid tumors, small‐cell carcinomas of the ovary, hypercalcemic type (SCCOHTs), and non‐small‐cell lung cancers (NSCLCs).3